Growth In Vitro of tumour cell × fibroblast hybrids in which malignancy is suppressed
Open Access
- 1 June 1977
- journal article
- Published by The Company of Biologists in Journal of Cell Science
- Vol. 25 (1) , 73-86
- https://doi.org/10.1242/jcs.25.1.73
Abstract
We have studied the growth in vitro of a lymphoma × fibroblast hybrid and several melanoma × fibroblast hybrids in which malignancy is suppressed. The parental cells, the hybrids, and malignant segregants derived from the hybrids were analysed for serum requirement, cloning efficiency in soft agarose, density-dependent inhibition of growth, and secretion of plasminogen-activating enzyme. One malignant segregant from the lymphoma × fibroblast cross was found by a number of criteria to have a more highly ‘transformed’ phenotype than the hybrid from which it was derived. However, in the case of the melanoma × fibroblast crosses, none of the parameters examined, could be correlated in a direct way with malignancy.Keywords
This publication has 15 references indexed in Scilit:
- Suppression of malignancy in human cellsNature, 1976
- Tumour promotor induces plasminogen activatorNature, 1976
- Control of growth of mammalian cells in cell cultureNature, 1975
- Cellular tumorigenicity in nude mice: Correlation with cell growth in semi-solid mediumCell, 1974
- Conditions Limiting Multiplication of Fibroblastic and Epithelial Cells in Dense CulturesNature, 1973
- AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSESThe Journal of Experimental Medicine, 1973
- AN ENZYMATIC FUNCTION ASSOCIATED WITH TRANSFORMATION OF FIBROBLASTS BY ONCOGENIC VIRUSESThe Journal of Experimental Medicine, 1973
- Topoinhibition and Serum Requirement of Transformed and Untransformed CellsNature, 1970
- Suppression of Malignancy by Cell FusionNature, 1969
- A substance in conditioned medium which enhances the growth of small numbers of chick embryo cellsExperimental Cell Research, 1966